The Addiction Policy Forum joined a national letter of support for continued funding of the Second Chance Act in the Fiscal Year 2027 Commerce, Justice, Science, and Related Agencies Appropriations bill.  The national sign-on letter calls on Congress to maintain funding for these proven reentry initiatives, which help individuals successfully reintegrate by increasing access to housing, employment, behavioral health care, and other essential services. Ongoing support will ens

Despite growth in the use of medications used to treat opioid use disorder (OUD) – including methadone, buprenorphine, and naltrexone – most people with OUD in the United States still do not receive medication. National estimates show only 25% of individuals with OUD receive medications for OUD (MOUD), underscoring a persistent gap between need and access. Research published in   JAMA Health Forum  found methadone treatment among Medicaid enrollees increased substantially ove

Sleep disturbance is a common, yet often overlooked, part of substance use disorders (SUDs). During withdrawal, many people report difficulty falling asleep and staying asleep, and sleep disturbance may persist during long-term recovery. The severity of sleep disturbances have also shown to be a predictor of relapse and later substance use (Gyawali & James, 2023 ). With alcohol use disorder (AUD) specifically, insomnia is frequently reported, and untreated insomnia has been i

On February 2, 2026, the Substance Abuse and Mental Health Services Administration (SAMHSA) announced the distribution of $794 million in federal block grant funding to support community-based mental health services and substance use prevention, treatment, and recovery programs nationwide. The funding includes $319 million through SAMHSA’s Community Mental Health Services Block Grant (MHBG), which supports services for adults with serious mental illness and children with seri

Findings from a National Institute on Drug Abuse (NIDA) study show that quitting cigarette smoking is associated with improved recovery outcomes from other substance use disorders. Using data from more than 2,600 adults participating in the Population Assessment of Tobacco and Health (PATH) Study, a nationally representative study funded by the National Institutes of Health (NIH) and the U.S. Food and Drug Administration, researchers examined changes in smoking status and re

Neuromodulation is gaining attention as an effective approach for treating substance use disorders. These techniques work by using electrical, magnetic, or soundwave stimulation to stimulate brain circuits affected by addiction. Research shows encouraging results in reducing craving and relapse risk. This webinar provides an overview of neuromodulation, including the various techniques and how they work, and what current research indicates about their potential role in addi